nafld and glutathione liposomal nonalcoholic fatty liver disease Nonalcoholic fatty liver disease: Current therapies future perspectives in drug delivery Targeting cell death in NAFLD:
Description
HIF-1 is required for disturbed flow-induced metabolic reprogramming in human and porcine vascular endothelium
AD, atopic dermatitis
D.J.B.: conceptualisation, design, methodology, investigation, writingreview and editing, visualisation, funding, supervision
Misinformation about MAOIs and the understanding on how to avoid potential dietary and drug-drug interactions has limited their use
